Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Picard Medical, Inc.
Picard Medical has entered into an exchange agreement to surrender all warrants issued in its December 2025 private placement in exchange for 200,000 shares of common stock. This transaction results in the immediate cancellation of the warrants and settles all related liquidated damages and potential legal claims against the company.…more
Picard Medical, Inc.
Picard Medical has filed a registration statement for the resale of up to 500,000 shares of common stock, consisting of 250,000 shares issuable upon conversion of $1 million in unsecured convertible notes issued on September 30, 2026, and 250,000 shares issuable upon the exercise of warrants. This registration facilitates potential sales by selling stockholders and will not result in any proceeds to the company.…more
Picard Medical, Inc.
Picard Medical, Inc. amended its bylaws on October 7, 2026, to reduce the quorum requirement for stockholder meetings from a majority of the voting power to 33 1/3% of the voting power. This change was implemented immediately to comply with the minimum quorum requirements under Delaware General Corporation Law and NYSE American rules.…more
21 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
India Government Seeking Nationwide Crackdown On Nicotine Pouches Due To Health Risks…more
The Indian Ministry of Health is seeking a nationwide crackdown on nicotine pouches citing significant health risks. This regulatory move could create substantial business uncertainty for companies operating in the Indian market.…more
●●●●●●●● ●●●●● ●●●●●●
Picard Medical reported a 39% year-over-year revenue increase that surpassed analyst expectations, though the company's per-share loss was wider than projected. Despite the revenue growth, the company remains unprofitable, warranting caution for investors.…more
●●●●●●●● ●●●●● ●●●●●●
Picard Medical reported Q2 revenue of $2.954 million, surpassing analyst estimates, but its loss per share of $3.05 significantly missed expectations. Despite the top-line growth, the increased net loss highlights ongoing profitability challenges.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.